Literature DB >> 17261336

Efficacy of an intensive prevention program in coronary patients in primary care, a randomised clinical trial.

Miguel-Angel Munoz1, Joan Vila, Marta Cabañero, Carolina Rebato, Isaac Subirana, Joan Sala, Jaume Marrugat.   

Abstract

BACKGROUND: Most studies that have analysed the effect of secondary prevention of coronary heart disease come from hospitals. Those that are community-based have been conducted mainly by nurses and follow-up was generally too short to show impact on cardiovascular events.
METHODS: This is a multi-centre randomised controlled clinical trial in which patients in the intervention group received periodic postal reminders to see their general practitioner every three months during a 3-year follow-up. General practitioners reinforced healthy lifestyle recommendations to patients and reviewed drug therapies at these quarterly intervals. Patients in the control group received usual care.
RESULTS: A total of 983 patients aged 30-79 were included. During the 3-year follow-up, 67 patients died and 156 experienced a non-fatal cardiovascular event. The event rates and all-cause mortality were similar in the intervention and control groups (24.0% and 23.5%, and 8.1% and 9.9%, respectively). Improvement in quality of life was similar in both groups. Blood pressure and high-density lipoprotein cholesterol were more frequently within recommended levels in the intervention group than in controls: odds ratio 1.63, 95% confidence interval 1.05-2.51, and odds ratio 2.61, 95% confidence interval 1.32-5.18, respectively.
CONCLUSIONS: Intensive secondary prevention conducted by general practitioners may improve long-term blood pressure control and increase high-density lipoprotein cholesterol in patients with stable coronary disease.

Entities:  

Mesh:

Year:  2007        PMID: 17261336     DOI: 10.1016/j.ijcard.2006.07.015

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  8 in total

Review 1.  Primary care organisational interventions for secondary prevention of ischaemic heart disease: a systematic review and meta-analysis.

Authors:  Edel Murphy; Akke Vellinga; Molly Byrne; Margaret E Cupples; Andrew W Murphy; Brian Buckley; Susan M Smith
Journal:  Br J Gen Pract       Date:  2015-07       Impact factor: 5.386

2.  Systematic review of the effect of diet and exercise lifestyle interventions in the secondary prevention of coronary heart disease.

Authors:  Judith A Cole; Susan M Smith; Nigel Hart; Margaret E Cupples
Journal:  Cardiol Res Pract       Date:  2010-12-19       Impact factor: 1.866

Review 3.  Meta-regression analyses to explain statistical heterogeneity in a systematic review of strategies for guideline implementation in primary health care.

Authors:  Susanne Unverzagt; Frank Peinemann; Matthias Oemler; Kristin Braun; Andreas Klement
Journal:  PLoS One       Date:  2014-10-24       Impact factor: 3.240

Review 4.  Can We Identify the Active Ingredients of Behaviour Change Interventions for Coronary Heart Disease Patients? A Systematic Review and Meta-Analysis.

Authors:  Laura Goodwin; Giovanni Ostuzzi; Nadia Khan; Matthew H Hotopf; Rona Moss-Morris
Journal:  PLoS One       Date:  2016-04-22       Impact factor: 3.240

5.  Effectiveness of a new health care organization model in primary care for chronic cardiovascular disease patients based on a multifactorial intervention: the PROPRESE randomized controlled trial.

Authors:  Domingo Orozco-Beltran; Esther Ruescas-Escolano; Ana Isabel Navarro-Palazón; Alberto Cordero; María Gaubert-Tortosa; Jorge Navarro-Perez; Concepción Carratalá-Munuera; Salvador Pertusa-Martínez; Enrique Soler-Bahilo; Francisco Brotons-Muntó; Jose Bort-Cubero; Miguel Angel Nuñez-Martinez; Vicente Bertomeu-Martinez; Vicente Francisco Gil-Guillen
Journal:  BMC Health Serv Res       Date:  2013-08-02       Impact factor: 2.655

6.  A novel programme to evaluate and communicate 10-year risk of CHD reduces predicted risk and improves patients' modifiable risk factor profile.

Authors:  J S Benner; L Erhardt; M Flammer; R A Moller; N Rajicic; K Changela; C Yunis; S B Cherry; Z Gaciong; E S Johnson; M C J M Sturkenboom; J García-Puig; X Girerd
Journal:  Int J Clin Pract       Date:  2008-08-07       Impact factor: 2.503

Review 7.  Personalized medicine and stroke prevention: where are we?

Authors:  Joosup Kim; Amanda G Thrift; Mark R Nelson; Christopher F Bladin; Dominique A Cadilhac
Journal:  Vasc Health Risk Manag       Date:  2015-12-02

8.  Six-year follow-up of the SPHERE RCT: secondary prevention of heart disease in general practice.

Authors:  A W Murphy; M E Cupples; E Murphy; J Newell; C J Scarrott; A Vellinga; P Gillespie; M Byrne; C Kearney; S M Smith
Journal:  BMJ Open       Date:  2015-11-03       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.